Trial of Oral Glutamine in Patients With Sickle Cell Anemia
A Randomized Controlled Trial of Oral Glutamine Supplementation Versus a Placebo Supplement in Children With Sickle Cell Anemia
Sponsor: St. Jude Children's Research Hospital
Terminated
Due to slow participant accrual
Other terminated trials from St. Jude Children's Research Hospital
- Heavy Menstrual Bleeding · Jan 2026
- Cataracts Infantile · Sep 2025
- Brain and Central Nervous System Tumors · Sep 2025
- Healthy Participants · Phase PHASE1 · Jul 2025
- Quality of Life · Feb 2025
See all terminations from St. Jude Children's Research Hospital
Other Anemia, Sickle Cell trials with similar outcome
This PHASE2 trial investigates Anemia, Sickle Cell and is currently terminated or withdrawn. St. Jude Children's Research Hospital leads this study, which shows 7 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
May 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- St. Jude Children's Research Hospital
- Thrasher Research Fund
For direct contact, visit the study record on ClinicalTrials.gov .